Agilent returned for a round that pushed the medical device developer's overall funding past the $50m mark and which will go to commercialising its Slim technology.
US-based biomedical equipment developer Mobilion Systems completed a $35m series B round yesterday that included diagnostics services provider Agilent Technologies.
Life sciences-focused venture capital fund aMoon led the round, which also featured pension fund, VC firm Cultivation Capital and commercialisation firm IP Group, which invested both directly and through its North American subsidiary.
Mobilion provides scientific apparatus to help biopharmaceutical researchers separate, identify and analyse proteins, and examine molecules such as glycans, which existing methods struggle to determine.
The company’s…
